Q4 2024 Earnings Call Transcript January 28, 2025 Stryker Corporation beats earnings expectations. Reported EPS is $4.01, ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Welcome to Stryker's fourth quarter earnings call ... including our Q Guidance System, Copilot and Mako Spine. These portfolio decisions reflect a continuation of our strategy to drive category ...

Stryker's Mako shoulder robot earned FDA approval in December, Jason Beach, vice president of finance and investor relations, said in a Jan. 28 earnings call.

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

Stryker, one of the world’s largest medtech companies, announced on January 28 that it would be selling its Spinal Implants business to ...

Medical technology company Stryker plans to sell its U.S. spinal implants business to investment firm Viscogliosi Brothers ...

Stryker will benefit from a strategic partnership with VB Spine, gaining exclusive access to innovative technologies like Mako Spine and Copilot for spinal procedures. The sale includes a binding ...

Stryker (SYK) announced a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers to create a newly formed ...

Stryker Corporation SYK reported fourth-quarter ... knee procedures and momentum from the continued strength of its new Mako installations. Our model estimated Orthopedics sales to be $2.57 ...

Analyst Patrick Wood from Morgan Stanley maintained a Buy rating on Stryker (SYK – Research Report) and keeping the price target at ...